RE:RE:RE:RE:RE:Cash position It's worth remembering these are late stage cancer patients with less than 6 months of life expectancy often the last month or two they come of drugs due to wide spread metastasis and drug side effects so although it's not directly related to efficacy if they have been on the drug for a longer period of time for one the drug has good safety profile and secondly it might have extended their life due to efficacy and yes all we can speculate about for now is it MIGHT..
jfm1330 wrote: That's a lot of hinting don't you think? And again, you can see what you want in patient #2 . If that's a hint of efficacy, it's a very weak hint. You don't base an investment decision on that.
SPCEO1 wrote: TH has already hinted about hints of efficacy with patient #2.